The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces reinterventions, and preserves future treatment options.1 The IN.PACT Admiral DCB is indicated for de novo, restenotic, or in-stent restenotic lesions up to 360 mm with reference vessel diameters of 4 to 7 mm in the superficial femoral or popliteal arteries.Product Details
The IN.PACT™ AV drug-coated balloon (DCB) enables you to get ahead of AV fistula restenosis by treating the cause — not just the symptoms of fistula stenosis — so you can go longer between interventions and help preserve the fistula for dialysis.2Product Details
Laird J. IN.PACT SFA 5-year Results. Presented at VIVA 2018; Las Vegas, NV.
Results from the IN.PACT™ AV Access Clinical Trial found in the IN.PACT™ AV drug-coated balloon (DCB) Instructions For Use (IFU).